This article is more than 5 years old. Information may no longer be current.

Sandoz voluntarily recalls more than 1 million units of Zyrtec

Sandoz issued a voluntary recall of 1,023,430 units of Zyrtec (10 mg) capsules as a result of failed impurities and a specification being reported for impurity at the 21 month stability time point, according to an FDA Enforcement Report.

Zyrtec (cetirizine) is an anti-histamine that is used to treat cold or allergy symptoms such as sneezing, itching, watery eyes, or runny nose, as well as itching and swelling caused by chronic urticaria.

The recall is in 6-tablets in one blister, in 12 (2 blisters) and 24 (4 blisters) tablet count configurations.